FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Respironics Recalls Garbin Ventilators

Philips Respironics recalls (Class 1) its Garbin Evo ventilators due to the potential for aerosol deposit accumulation on the devices internal flow se...

latest-news-card-1
Human Drugs

Innovative Manufacturing Technologies Comments

Two stakeholder trade associations suggest changes to an FDA strategy document on innovative manufacturing technologies.

latest-news-card-1
FDA General

Trump Taps RFK Jr. as HHS Secretary

President-elect Donald Trump picks controversial FDA critic and vaccine skeptic Robert F. Kennedy Jr. as his secretary for Health and Human Services.

latest-news-card-1
Human Drugs

Require Studies for Prednisolone Eye Drops: DifGen

DifGen asks FDA to require long-term refrigerated stability studies for any generic form of its Prednisolone Ophthalmic Solution 1%.

latest-news-card-1
Human Drugs

Workshop on Patient Experience Data

Federal Register notice: FDA announces a 12/13 virtual public workshop entitled Patient-Focused Drug Development: Workshop to Discuss Methodologic and...

latest-news-card-1
Biologics

Adaptimmune Therapeutics Plan Lete-Cel BLA

Adaptimmune Therapeutics plans a rolling BLA submission for cell therapy lete-cel in certain people with synovial sarcoma or myxoid/round cell liposar...

latest-news-card-1
Human Drugs

7 Observations on U.S. Specialty FDA-483

FDA releases the form FDA-483 with seven observations from an inspection at the U.S. Specialty Formulations outsourcing facility in Allentown, PA.

latest-news-card-1
Human Drugs

Oligonucleotide-Based Therapeutic Assessment

FDA publishes a draft guidance on the nonclinical safety assessment of oligonucleotide-based therapeutics.

latest-news-card-1
Medical Devices

NovaBone Putty Cleared for Intervertebral Disc Repair

FDA clears a NovaBone Products 510(k) for its NovaBone Putty and its expanded use in the intervertebral disc space.

latest-news-card-1

SCOTUS Decisions Effect on FDA Analyzed

Six Squire Patton Boggs attorneys lay out the impact of four recent Supreme Court decisions on several aspects of FDA regulation.